Wells Fargo’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,338
Closed -$1.5K 7098
2025
Q2
$1.5K Hold
1,338
﹤0.01% 6252
2025
Q1
$1.69K Hold
1,338
﹤0.01% 6181
2024
Q4
$3.04K Sell
1,338
-2,180
-62% -$4.03K ﹤0.01% 6138
2024
Q3
$12.2K Buy
3,518
+1,597
+83% +$7.54K ﹤0.01% 5750
2024
Q2
$9.75K Sell
1,921
-20
-1% -$150 ﹤0.01% 5750
2024
Q1
$16.4K Sell
1,941
-51
-3% -$280 ﹤0.01% 5633
2023
Q4
$8.16K Sell
1,992
-700
-26% -$2.1K ﹤0.01% 5881
2023
Q3
$8.08K Buy
2,692
+202
+8% +$4.59K ﹤0.01% 5848
2023
Q2
$76.9K Buy
2,490
+836
+51% +$34.6K ﹤0.01% 5195
2023
Q1
$81.9K Buy
1,654
+329
+25% +$9.54K ﹤0.01% 4910
2022
Q4
$32.6K Sell
1,325
-34
-3% -$1.27K ﹤0.01% 5055
2022
Q3
$90K Buy
1,359
+166
+14% +$8.32K ﹤0.01% 4668
2022
Q2
$50K Buy
1,193
+111
+10% +$5K ﹤0.01% 5010
2022
Q1
$55K Sell
1,082
-155
-13% -$7.61K ﹤0.01% 5604
2021
Q4
$74K Buy
1,237
+358
+41% +$17.6K ﹤0.01% 5776
2021
Q3
$44K Buy
879
+25
+3% +$1.31K ﹤0.01% 5677
2021
Q2
$49K Sell
854
-1,184
-58% -$63.3K ﹤0.01% 5563
2021
Q1
$116K Sell
2,038
-4,807
-70% -$363K ﹤0.01% 5417
2020
Q4
$465K Buy
6,845
+2,346
+52% +$319K ﹤0.01% 4569
2020
Q3
$1.14M Buy
4,499
+544
+14% +$111K ﹤0.01% 3753
2020
Q2
$665K Buy
3,955
+2,915
+280% +$314K ﹤0.01% 4122
2020
Q1
$73K Buy
1,040
+707
+212% +$55.2K ﹤0.01% 5204
2019
Q4
$21K Hold
333
﹤0.01% 5728
2019
Q3
$20K Sell
333
-9
-3% -$531 ﹤0.01% 5804
2019
Q2
$20K Buy
342
+9
+3% +$524 ﹤0.01% 5788
2019
Q1
$22K Hold
333
﹤0.01% 5514
2018
Q4
$18K Sell
333
-637
-66% -$31.4K ﹤0.01% 5800
2018
Q3
$56K Buy
970
+14
+1% +$846 ﹤0.01% 5555
2018
Q2
$56K Hold
956
﹤0.01% 5563
2018
Q1
$45K Buy
956
+200
+26% +$10.1K ﹤0.01% 5598
2017
Q4
$44K Buy
756
+356
+89% +$21.3K ﹤0.01% 5598
2017
Q3
$25K Buy
400
+67
+20% +$4.34K ﹤0.01% 5650
2017
Q2
$21K Hold
333
﹤0.01% 5620
2017
Q1
$21K Buy
333
+66
+25% +$3.44K ﹤0.01% 5697
2016
Q4
$10K Hold
267
﹤0.01% 5802
2016
Q3
$10K Buy
+267
New +$9.99K ﹤0.01% 5754

Other funds holding BCLI